Your browser doesn't support javascript.
loading
Integrative medicine during the intensive phase of chemotherapy in pediatric oncology in Germany: a randomized controlled trial with 5-year follow up.
Seifert, Georg; Blakeslee, Sarah B; Calaminus, Gabriele; Kandil, Farid I; Barth, Andrea; Bernig, Toralf; Classen, Carl Friedrich; Corbacioglu, Selim; Föll, Jürgen; Gottschling, Sven; Gruhn, Bernd; Vom Hoff-Heise, Claudia; Lode, Holger N; Martin, David; Nathrath, Michaela; Neunhoeffer, Felix; Pekrun, Arnulf; Wulff, Beate; Zuzak, Tycho; Henze, Günter; Längler, Alfred.
Afiliação
  • Seifert G; Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany. georg.seifert@charite.de.
  • Blakeslee SB; Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Calaminus G; Department of Pediatric Hematology and Oncology, University Children's Hospital, Düsseldorf, Germany.
  • Kandil FI; Department of Pediatric Hematology and Oncology, University Hospital Bonn, University of Bonn, Bonn, Germany.
  • Barth A; Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Bernig T; Institute of Applied Analysis and Numerical Simulation, Research Group for Computational Methods for Uncertainty Quantification, University of Stuttgart, Stuttgart, Germany.
  • Classen CF; Department of Pediatrics, Martin Luther University Halle-Wittenberg, Halle, Germany.
  • Corbacioglu S; Division of Pediatric Oncology, Hematology and Palliative Medicine Section, Department of Pediatrics and Adolescent Medicine, University Medicine Rostock, Rostock, Germany.
  • Föll J; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital Regensburg, Regensburg, Germany.
  • Gottschling S; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University Hospital Regensburg, Regensburg, Germany.
  • Gruhn B; Center for Palliative Care and Pediatric Pain Medicine, Saarland University Medical Center, Homburg, Germany.
  • Vom Hoff-Heise C; Department of Pediatrics, Jena University Hospital, Jena, Germany.
  • Lode HN; Department of Pediatrics, Division of Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Martin D; Department of Pediatric Hematology and Oncology, University Medicine, Greifswald, Germany.
  • Nathrath M; Department of Hematology Oncology, University Children's Hospital, Tübingen, Germany.
  • Neunhoeffer F; Department of Human Medicine, Faculty of Health, University Witten/Herdecke, Herdecke, Germany.
  • Pekrun A; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany.
  • Wulff B; Pediatric Oncology Center, Department of Pediatrics, Technische Universität München, Munich, Germany.
  • Zuzak T; Department of Pediatric Cardiology, Pulmonology and Pediatric Intensive Care Medicine, University Children's Hospital, Tübingen, Germany.
  • Henze G; Department of Pediatric Hematology and Oncology, Hospital Bremen-Mitte, Bremen, Germany.
  • Längler A; Department of Pediatric Hematology-Oncology, Pediatrics III, University Hospital of Essen, Essen, Germany.
BMC Cancer ; 22(1): 652, 2022 Jun 13.
Article em En | MEDLINE | ID: mdl-35698215

Texto completo: 1 Base de dados: MEDLINE Medicinas Complementares: Medicina_antroposofica Assunto principal: Medicina Integrativa / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMC Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Medicinas Complementares: Medicina_antroposofica Assunto principal: Medicina Integrativa / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMC Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha